Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01594021Phase 4Terminated
Phase 4, randomised trial of gelatin in arterial hypotension (2 arms), sponsored by Hôpital Foch. Primary endpoint: Hypotension at 30 minutes. Started Jul 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01594021.